CXM's Excellarate is the first DNA-based treatment for diabetic foot ulcer. And statistically, the healing process is occurring faster than any other treatment. The phase IIb results will be announced by October 14th.
CXM: The next HGSI
(2009-10-13 13:05:05) 评论 (1)CXM's Excellarate is the first DNA-based treatment for diabetic foot ulcer. And statistically, the healing process is occurring faster than any other treatment. The phase IIb results will be announced by October 14th.